Search research articles
Contact Us
Filters
Showing results (301-310 of 331) with videos related to
Page
of 34
Sort By:
Annals of the American Thoracic Society
|
September 17, 2025
Long-term Reductions in Inflammation in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor
Scott D Sagel, T Spencer Poore, Brandie D Wagner, et al.
Contemporary Clinical Trials
|
November 18, 2024
Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study
Jill Maggs, Gregory S Sawicki, Callie Bacon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 16, 2023
Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis
Scott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
Isabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
Plos One
|
May 5, 2022
Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial
Silvia M Caceres, Linda A Sanders, Noel M Rysavy, et al.
Annals of the American Thoracic Society
|
January 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design
Nicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis, et al.
Journal of Diabetes Research
|
December 22, 2016
Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes
J L Taylor-Cousar, J S Janssen, A Wilson, et al.
Lab on a Chip
|
May 6, 2022
A microfluidic device and instrument prototypes for the detection of <i>Escherichia coli</i> in water samples using a phage-based bioluminescence assay
Luis F Alonzo, Troy C Hinkley, Andrew Miller, et al.
BMJ Open
|
April 15, 2020
Usual care and a self-management support programme versus usual care and a relaxation programme for people living with chronic headache disorders: a randomised controlled trial protocol (CHESS)
Shilpa Patel, Felix Achana, Dawn Carnes, et al.
ERJ Open Research
|
December 3, 2025
Home sputum collection for <i>Aspergillus fumigatus</i> detection in adults with cystic fibrosis
Gina Hong, Joanna Walsh, Allen Koshy, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 331) with videos related to
Sort By:
Page
of 34
Annals of the American Thoracic Society
|
September 17, 2025
Long-term Reductions in Inflammation in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor
Scott D Sagel, T Spencer Poore, Brandie D Wagner, et al.
Contemporary Clinical Trials
|
November 18, 2024
Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study
Jill Maggs, Gregory S Sawicki, Callie Bacon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 16, 2023
Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis
Scott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
Isabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
Plos One
|
May 5, 2022
Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial
Silvia M Caceres, Linda A Sanders, Noel M Rysavy, et al.
Annals of the American Thoracic Society
|
January 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design
Nicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis, et al.
Journal of Diabetes Research
|
December 22, 2016
Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes
J L Taylor-Cousar, J S Janssen, A Wilson, et al.
Lab on a Chip
|
May 6, 2022
A microfluidic device and instrument prototypes for the detection of <i>Escherichia coli</i> in water samples using a phage-based bioluminescence assay
Luis F Alonzo, Troy C Hinkley, Andrew Miller, et al.
BMJ Open
|
April 15, 2020
Usual care and a self-management support programme versus usual care and a relaxation programme for people living with chronic headache disorders: a randomised controlled trial protocol (CHESS)
Shilpa Patel, Felix Achana, Dawn Carnes, et al.
ERJ Open Research
|
December 3, 2025
Home sputum collection for <i>Aspergillus fumigatus</i> detection in adults with cystic fibrosis
Gina Hong, Joanna Walsh, Allen Koshy, et al.
Page
of 34